Abstract
Mesangial cells stimulated with high glucose (HG) exhibit increased intracellular angiotensin II (AngII) synthesis that is correlated with the upregulation of AngII target genes, such as profibrotic cytokines. The intracrine effects of AngII can be mediated by several molecules transferred to other cells via exosomes (Exos), which play a key role in cellular communication under many physiological and pathological conditions. The aim of this study was to investigate the effects of exosomes derived from HG-stimulated human mesangial cells (HG-HMCs) on normal unstimulated HMCs. Exosomes from HMCs (C-Exos) and HG-HMCs (HG-Exos) were obtained from cell culture supernatants. HMCs were incubated with C-Exos or HG-Exos. HG stimulus induced a change in the amount but not the size of Exos. Both C-Exos and HG-Exos contained angiotensinogen and renin, but no angiotensin converting enzyme was detected. Compared with HMCs treated with C-Exos, HMCs treated with HG-Exos presented higher levels of fibronectin, angiotensinogen, renin, AT1 and AT2 receptors, indicating that HG-Exos modified the function of normal HMCs. These results suggest that the intercellular communication through Exos may have pathophysiological implications in the diabetic kidney.
Subject terms: Mechanisms of disease, Molecular biology, Diabetic nephropathy
Introduction
Intercellular communication plays a key role in regulating physiological and pathophysiological processes. Exosomes, which are released by most cells, constitute an important pathway in cell communication1,2. Exosomes can be taken up and deliver many signaling molecules to neighboring or distant cells3–8.
The molecular content of exosomes is determined by secretory cells and is regulated by the cellular physiology; however, it can be altered under pathophysiological conditions9. Thus, exosomes can be produced and secreted with altered contents in response to many stimuli, such as changes in oxygen tension, modifications in the glucose supply and cytotoxic drugs7,10.
The involvement of exosomes in cell communication has been demonstrated in many pathologies, such as tumor growth and metastasis formation11–13, as well as other pathologies, including hepatic6, neurodegenerative14 and renal6 diseases.
Diabetes mellitus and its secondary manifestations are directly involved in the onset of renal damage, representing one of the main causes of chronic kidney disease15–17. Mesangial cell activation in response to hyperglycemia results in the increased synthesis of the mesangial matrix and the mesangial expansion contributing to progressive glomerular damage. In addition, in vitro studies using mesangial cells (MC) in culture showed that excess glucose is a potent stimulus for intracellular synthesis and the release of AngII18,19, contributing to the intrarenal AngII overproduction, a hallmark diabetic nephropathy (DN)20. AngII plays a pivotal local role in the progression of renal disease by its proinflammatory and profibrotic effects20–24.
Chronic kidney disease has a progressive nature, and cellular communication plays a crucial role in this process20,25–28; however, the participation of exosomes in this process has not been fully explored. We hypothesized that high-glucose activated MCs could influence neighboring healthy cells through cell-to-cell communication via exosomes. Thus, the present study evaluated the biology and contents of the exosomes secreted by high glucose-activated human MCs (HMCs) and examined their potential role in the transfer of information to control cells. Exosomal cargo was analyzed in terms of fibrotic molecules and the components of the renin angiotensin system (RAS). The contents of the exosomes released by HMCs stimulated by high glucose were also evaluated and whether these exosomes would be able to alter the function of unstimulated target cells was determined. The obtained results are consistent with the hypothesis that high glucose-activated HMCs could influence neighboring healthy cells through cell-to-cell communication via exosomes.
Results
Characterization of exosomes from HMCs cultured under control and high-glucose conditions
Initially, we verified whether HMCs could release exosomes and examined the role of high-glucose in this process. Exosomes released by HMCs were collected and evaluated at 4, 8, 16 and 24 hr. The results showed that HG-stimulated HMCs released a higher number of exosomes compared to unstimulated cells with significance after incubation for 16 and 24 hr (Fig. 1).
Exosomes were characterized according to their shapes and sizes by transmission electron microscopy (TEM). As shown in Fig. 2A, the spherical vesicles presented typical cup-shaped exosomes (Fig. 2B). There were no morphological differences between the C-Exos and HG-Exos groups. Figures 2C,D show vesicles of variable sizes. The presence of the exosomal markers CD63 and CD81 tetraspanins was evidenced by western blotting (Fig. 2E). Finally, the particle size was analyzed by screening nanoparticles, and as shown in Fig. 2F, both groups showed similar profiles for particle size, with a mean of 135 nm, compatible with exosome size. However, a higher number of particles were identified in the HG-Exos group compared to the C-Exos group, as also shown in Fig. 1.
These results indicated that HMC produced and released extracellular vesicles of sizes and shapes compatible with exosomes. Cellular stimulation with a high glucose concentration did not alter the shapes and sizes of the exosomes but significantly influenced the number of particles released.
Exosomes were internalized by HMCs
To evaluate the ability of normal HMCs to take up exosomes, we labeled HG-Exos with PKH26 (red fluorescent lipidic marker). The cellular uptake of HG-Exos was observed under confocal laser microscopy (Fig. 3A). After the 3-hr incubation period, PKH26-labeled HG-Exos were localized in the cytoplasm of HMCs, indicating that exosomes were internalized by the cells.
Uptake of C-Exos (Fig. 3B) and HG-Exos (Fig. 3C) by control HMCs was also verified by electron microscopy. Vesicle incorporation into cell can be observed (black arrows), shown in detail with a larger size. The fluorescence intensity of the images of HG-Exos labeled with PKH26 (red) at different depths (z) is demonstrated in Supplemental Fig. 3A. The addition of the dye alone did not produce intracellular labeling, which indicates that intracellular labeling observed in the Fig. 3A is due to internalization of exosomes into cell. (Supplemental Fig. 3B).
Content of Exosomes
Since mesangial cells are an important intrarenal source of the components of the renin angiotensin system (RAS), the presence angiotensinogen (AGT), renin and angiotensin-converting enzyme (ACE) in the C-Exos and HG-Exos was evaluated by western blotting. The results showed that the C-Exos protein extract constitutively contained renin and angiotensinogen proteins (Fig. 4A), but no ACE was detected, as shown in Fig. 4D. The positive control for ACE expression was obtained in mouse lung extract. Densitometric analysis of the bands (Fig. 4B,C) showed that renin and angiotensinogen proteins were increased in HG-Exos compared to C-Exos.
To examine the ability of HMC-derived exosomes to induce the de novo synthesis of intracellular AngII, we used CHO-K1 cells since this cell line does not express RAS components29. Considering that exosomes derived from HMCs did not contain ACE, another group of CHO cells was transfected with ACE (ACE-CHO). CHO-K1 and ACE-CHO cells were incubated with C-Exos or HG-Exos in the presence or absence of the ACE inhibitor captopril. As expected, ACE-CHO expressed ACE (Fig. 5A). After incubation for 24 hr, the presence of AngII in ACE-CHO was analyzed by immunofluorescence under a confocal laser microscope. CHO-K1 and ACE-CHO cells alone did not express AngII (Fig. 5B, upper panel). In contrast, ACE-CHO cells exposed to either C-Exos or HG-Exos showed AngII staining, indicating that AngII was synthesized from the contents released by the exosomes (Fig. 5B, middle panels). AngII labeling was not observed in the presence of captopril (Fig. 5B, lower panels). The same experiment was performed with CHO-K1 (non-transfected cells). As expected, the presence of ACE was not observed in these cells (Supplemental Fig. 4A). In addition, no AngII staining was observed in CHO-K1 treated with either C-Exos or HG-Exos (Supplemental 4B). These results indicate that C-Exos and HG-Exos can contribute to AngII synthesis in target cells.
HG and HG-Exos increased the expression of AT1 and AT2 receptors
To assess whether HG-Exos would induce HMC to increase the expression of AT1 and AT2 receptors in both whole HMC and in the isolated nuclei, we incubated HMCs with HG, C-Exos or HG-Exos for 24 hr. The presence of the receptors in whole cells was assessed by immunofluorescence under confocal microscopy (Fig. 6A,B), while the presence of receptors in isolated nuclei was assessed by western blotting (Fig. 6C,D). Faint labeling for both AT1 (Fig. 6A) and AT2 (Fig. 6B) was observed; however, in the presence of either HG or HG-Exos, the labeling for both receptors was stronger. The same profile was observed in nuclei isolated from HMCs exposed to both HG or HG-Exos (Fig. 6C,D). Figure 6E showed representative bands of AT1 and AT2. Expression of the nuclear protein histone and absence of α-smooth muscle actin (α-SMA) and cytoplasm membrane S100A10 proteins confirmed the purity of the samples.
Activation of HMC by HG-Exos
To determine whether exosomes are involved in the cellular communication contributing to the perpetuation of the mesangial cell activation in the diabetic milieu, we added exosomes derived from HG-stimulated HMCs to the culture medium of healthy HMCs. The production of RAS components (AGT, renin and AT1 and AT2 receptors), cell proliferation and mesangial matrix production were estimated at 24 hr after the exposure of HMC to C-Exos or HG-Exos.
The gene expression of AGT (Fig. 7A) and fibronectin (Fig. 7B) was significantly increased in both HG-stimulated HMCs and HMCs exposed to HG-Exos. As osmotic control, 30 mM mannitol was added in HMC instead of glucose for 24 h (Mannitol group). From culture medium of HMC stimulated with mannitol, the exosomes (Mannitol-exos) were collected and added in normal HMCs and the gene expression of AGT and fibronectin was evaluated. Mannitol-exposed cells also presented an increase in AGT and fibronectin, but the mean value obtained did not differed significantly from control cells (Supplemental Fig. 5). AGT (7C), renin (7D), AT1 (7E) and AT2 (7F) proteins presented the same profile. Figure 7G showed representative bands of AGT, renin, AT1 and AT2. C-Exos treatment did not induce changes in either mRNA or protein expression. Cell proliferation was increased in HMCs incubated with HG or with HG-Exos in all periods at 0, 24, 48 and 72 hr (Fig. 7H).
Discussion
In diabetes, whether exosomes can mediate the communication among the mesangial cells and participate in the pathogenesis of DN remains unclear. To further define the role of HMC-derived exosomes, we used an in vitro model to test the hypothesis that exosomal signaling is responsive to the increased extracellular glucose concentration in HMCs. The main findings of the present study were as follows: (1) HMCs likely use intercellular communication mechanisms involving extracellular vesicles, including exosomes; (2) this mechanism is preserved in HMCs maintained under in vitro conditions; (3) exosomes purified from HMCs stimulated with high glucose presented higher amounts of RAS components; and 4) HG-Exos transmit the source cell information to unstimulated control cells that in turn respond with alterations similar to those induced by HG.
HMCs constitutively secreted exosomes, and the high-glucose stimulus induced an increase in the number of exosomes. A similar effect was also observed in trophoblastic cells7, suggesting that high levels of glucose can interfere with exosome bioactivity. This phenomenon may contribute to the signal amplification induced by the high-glucose milieu, where cells that react to HG stimulus can activate non-responsive cells, perpetuating the injury signaling.
The results showed that Exos secreted by HMCs cultured under standard conditions constitutively contained the components of the RAS, except ACE. Although certain cell surface proteins are found in the membrane of exosomes, we did not find the ACE in the exosomes. ACE is a typical extracellular membrane enzyme, thereby explaining the absence of ACE since exosomes are structures whose biosynthesis occurs from the intracellular compartment30,31, unlike the microvesicles released from the plasma membrane. Moreover, this result is in consistent with the mean size of the observed particles, which was compatible with exosomes32. These results suggest that information on intracellular RAS activity may be exchanged among cells through exosomes signaling, even under physiological conditions.
However, many stimuli, such as exposure to alcohol33, thermal shock34, oxidative stress35, hypoxia4,36, and acidic pH37, can modify the Exos contents, and in the present study, HMCs exposed to high glucose concentrations secreted Exos enriched with higher levels of renin and AGT than the Exos contents released by control HMCs. This finding is of particular importance since the increased intrarenal activity of RAS has been implicated in the pathogenesis of diabetic nephropathy38,39. Mesangial cells are a potential source of RAS components in the kidney and HG stimulates the intracellular synthesis of AngII in these cells18,19. Moreover, an increase in the local levels AngII has been implicated in the early manifestations of diabetic nephropathy characterized by mesangial expansion and the production of the profibrotic molecules such as fibronectin. Here, we demonstrated that the RAS activation induced by glucose in HMCs can be transmitted to other cells by exosomes. In fact, normal non-stimulated HMCs exposed to HG-Exos presented the same response observed in whole HMCs exposed to HG. This information transmission via exosomes was confirmed in non-RAS component-expressing CHO cells transfected with ACE. ACE-CHO cells displayed AngII labeling only when exposed to the Exos from HMCs, indicating that AngII was produced from the content released by the exosomes. Although Exos did not contain ACE, HMCs express ACE mRNA18 and exhibit ACE activity40, enabling HMCs to increase AngII synthesis from exosomal AGT and renin.
Hyperglycemia has a cytotoxic effect on mesangial cells41–44. In this study, we demonstrated that Exos derived from HMCs stimulated by the HG concentration influenced the phenotype of non-stimulated HMCs. Control HMCs stimulated by the HG-Exos showed increased AGT and renin contents, indicating that the cargo of HG-Exos was efficiently delivered to control cells, and contributed to increase RAS components in unstimulated target cells. As a phenotype response, it was observed a overproduction of fibronectin in HMC exposed to HG-Exos, an cell proliferation increase in target cells, and a similar effect was observed in whole HMCs stimulated with HG45,46.
We previously observed47 that the AngII receptors AT1 and AT2 are present in the cytoplasm and the nuclear membrane of HMCs, and these intracellular receptors may be involved in some of the intracellular responses of AngII, including gene activation. These responses are defined as the intracrine actions of AngII48–50. In the present study, we observed that HG induced the overexpression of both AT1 and AT2 receptors in the nuclear membranes of HMCs, and interestingly, the exosomes derived from HG-stimulated HMCs induced the same effect in the target cells. The pathophysiological relevance of the intracrine effect of AngII is not completely understood, but we speculated that the biological effects observed in HMCs stimulated with HG-Exos were triggered, at least in part, by the intracellular action of AngII.
Although the results obtained in this study strongly suggest that the information on RAS activity can be transmitted from cell to cell by exosome signaling in HMCs, these results do not exclude the transmission of other proteins, mRNAs or microRNAs present in the Exos from HMCs stimulated by the HG concentration, which could also play an important role in intercellular communication and cell phenotype modification. Taken together, these results indicate that the Exos from cells stimulated by high glucose change the phenotype of normal cells, suggesting that this mechanism of cellular communication may be important in the transmission and spread of changes to cells and tissues that are not directly affected.
In summary, the main results obtained in the present study suggest that (1) HMCs under standard culture conditions release Exos; (2) glucose is a factor that can regulate the release and interfere with the contents of Exos secreted by HMCs; and (3) Exos isolated from HMCs stimulated by glucose induced the production of profibrotic and biologically active substances with normal HMCs.
Exosome communication is active in HMCs and may have implications in the pathophysiology of diabetic nephropathy.
Experimental Procedures
Mesangial cell culture
Immortalized human mesangial cells (HMC) were provided by Dr. Bernhard Banas (Nephrology Center, University of Munich, Germany)51. The cells were grown at 37 °C in plastic flasks in Dulbecco’s Modified Eagle’s medium (DMEM, Invitrogen Corporation, Gaithersburg, MD, USA) containing 10% fetal bovine serum (FBS), penicillin (50 U/ml) and 2.6 g HEPES. The culture flasks were maintained in a 95% air and 5% CO2 humidified environment. At confluence, HMCs were exposed to culture medium containing no FBS for 24 hr according to the following experimental groups: the control group, cultured in DMEM containing a standard concentration of 5 mM D-glucose, and the High Glucose (HG) group, cultured for 48 hr in DMEM containing 30 mM D-glucose. Subsequently, the culture media were collected, and the exosomes were isolated from both groups. Then, HMCs were exposed to exosomes from control cells (Control-Exos group) or from HG-stimulated cells (HG-Exos group). After incubation for 24 h, the culture media were aspirated, and the cells were analyzed.
Exosome extraction
Differential centrifugation was used to extract exosomes from the serum-free HMC culture supernatants as previously described8. In brief, HMC culture supernatants were collected and sequentially centrifuged at 300 × g for 10 min, 2,000 × g for 20 min, and 10,000 × g for 30 min to remove lifted cells, cellular debris and large vesicles. The cleared samples were then subjected to ultracentrifugation at 100,000 × g for 120 min twice at 4 °C to pellet the exosomes (Exos). The resulting exos were resuspended in a small amount of PBS for direct use in subsequent studies.
Exos were obtained from supernatant after 2 hr of ultracentrifugation. As previously published methodologies diverge in the time of ultracentrifugation, a preliminary experiment was carried out to standardize the time to 1 or 2 hr of ultracentrifugation. As shown in Supplemental Fig. 1A, compared with ultracentrifugation for 1 hr, ultracentrifugation for 2 hr resulted in a larger number of particles. The size of the Exos was not altered by the ultracentrifugation time (Supplemental Fig. 1B). These findings confirm the presence of HMCs-derived Exos in our preparations and indicate that HG stimulated a higher release of Exos by HMCs.
Quantification of exosome particles
The size and concentration of exosomes from HMCs stimulated or not with high glucose was determined by nanoparticle tracking analysis (NTA) to measure the rate of Brownian motion to particle size by using a Malvern NanoSight (NS300) system (Worcestershire, UK) that tracks individual particles and the Stokes-Einstein equation to calculate their diameters. Three replicates of diluted aliquots of vesicle fractions (1 mL in PBS) were injected into the machine’s specimen chamber, and the vesicles were tracked and measured for 30 sec, three times for each sample, at a constant flow rate.
Transmission electron microscopy
Cells
Cultured HMCs were fixed in 4% formaldehyde (PFA; Polysciences Inc., 18814) and 2% glutaraldehyde (Sigma-Aldrich, 340855) in 0.1 M phosphate buffer, pH 7.4. After fixation, the samples were rinsed several times with PBS, followed by post-fixation in 1% osmium tetroxide (EMS, 19150) in phosphate buffer for 1 h. The samples were rinsed with PBS for 15 min and dehydrated through a series of graded ethanol washes ranging from 70% to 100%. The samples were subsequently immersed in an propylene oxide: epon mixture (1:1) and polymerized in pure epon (Polysciences, Inc. 02334-500) at 60 °C for 48 h. Ultrathin sections were stained with uranyl acetate and lead citrate and imaged at 80 kV on a JEOL 1200 EX II transmission electron microscope (JEOL, USA). Images were acquired with a GATAN 781 camera (USA).
Exosomes
Frozen, isolated exosomes were resuspended in 1% buffered formaldehyde, adsorbed onto formvar-carbon-coated electron microscopy grids (EMS, FCF200H-Cu), and fixed with a mixture of 2% formaldehyde for 20 min. A 50-µL drop of PBS was placed on a sheet of parafilm, and grids were transferred with the sample side facing down on the drop for 2 min. The grids were transferred to a 50-µL drop of 1% glutaraldehyde for 5 min prior to transfer to a 100-µL drop of distilled water for 2 min. Negative staining was performed by placing the grid over a 50-µL drop of uranyl-oxalate solution for 5 min (4% uranyl acetate, EMS, 22400-4; 0.15 M oxalic acid, Sigma-Aldrich, 75688 pH 7) before transfer to a 50-µL drop of methyl-cellulose-UA (4% uranyl acetate and 2% methyl cellulose for 10 min, Sigma-Aldrich, M6385, in a ratio of 100 µL:900 µL) on a glass dish covered with parafilm on ice. The grids were removed, and excess fluid was blotted gently onto Whatman no.1 filter paper. The grids were dried, stored in appropriate grid storage boxes, and subsequently observed under a JEOL 1200 EX II transmission electron microscope at 80 kV. Images were acquired with a GATAN 781 camera (USA).
Incorporation of exosomes
First, HMCs stimulated with high glucose-derived exosomes were labeled with red lipophilic fluorescent dye PKH26 (Sigma-Aldrich, St. Louis, MO) according to the manufacturer’s instructions. After labeling, the exosomes were incubated with normal cells for approximately 3 hr at 37 °C and viewed by a confocal microscope.
Western blot analysis
Total protein was purified from the cells and isolated nuclei extracts. The cell and nuclei suspensions were homogenized in ice-cold lysis buffer containing 50 mM Tris (pH 8.0), 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 2.5 mM ethylenediaminetetraacetic acid (EDTA), 1 mM phenylmethylsulfonyl fluoride (PMSF) and 44 mM o-phenanthroline (all reagents from Sigma-Aldrich Chemical Co., USA). The protein concentration was determined by the Lowry method (DC Protein Assay; Bio-Rad Laboratories Inc., Richmond, CA, USA). Equal amounts of total extracted proteins (50 μg) were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and then transferred onto a nitrocellulose membrane (Amersham Pharmacia Biotech, Piscataway, NJ, USA). Blots of nuclear protein were subjected to immunoblot analyses with primary polyclonal antibodies against AT1 (1:1000;) and AT2 (1:1000) receptors (Immuny, Brazil), the nuclear protein histone (1:1000; Sigma, USA), the cytosolic protein α-smooth muscle actin (α-SMA) (1:1000; Sigma-Aldrich, USA) and the plasma membrane protein S100A-10 (1:1000; Sigma, USA) to verify the purity of the sample.
Blots of cell protein were subjected to immunoblot analyses with the primary polyclonal antibodies against Angiotensinogen (1:1000; Sigma-Aldrich, USA), Renin (1:1000; Sigma-Aldrich, USA), AT1 and AT2.
Exosomal protein expression was verified by antibodies against CD63 (1:100, Abcam), CD81 (1:1000 Santa Cruz), renin, angiotensinogen and ECA (1:1000; Sigma-Aldrich, USA).
Immunodetection was achieved by incubating the blots in horseradish peroxidase-conjugated (HRP) anti-rabbit or anti-mouse secondary antibody (1:30,000 dilution). The protein bands were visualized using the Immobilon Western HRP substrate (Millipore). The obtained bands were quantified using the Luminescent Image Analyzer-LAS 4000 and Image Gauge V3.1 software (Fuji Photo Film Co, Tokyo, Japan).
Expression of AT1 and AT2 in nuclei of HMC
HMCs express AT1 and AT2 receptors in the nuclear membrane52, which mediate the nuclear effects of AngII. Thus, we investigated whether HG-HMC-derived exosomes could modify the distribution and number of nuclear receptors. Intact nuclei were isolated according to the protocol of Ho YF et al.53. In brief, after confluence, HMCs were trypsinized, transferred to a tube and centrifuged at 1200 g for 5 min. The cell pellet was resuspended into 4 mL of 0.25 M sucrose/TKM buffer (50 mM Tris-HCl, 5 mM MgCI, 25 mM KCl, pH 7.5). The suspension was centrifuged again at 600 g for 5 min. The suspension was divided into aliquots and transferred to separate ultracentrifuge tubes containing 2 volumes of 2.3 M sucrose/TKM. The contents were mixed by inversion. The mixture was carefully underlaid with 4 mL of 2.3 M sucrose/TKM and overlaid with TKM to fill the tube. The tubes were centrifuged at 25,000 g for 10 min. The pellet at the bottom of the tube contained the nuclei. The nuclear pellet was washed by resuspension in TKM, followed by centrifugation at 900 g for 5 min at 4 °C, and the resulting pellet contained highly purified nuclei, which were resuspended in phosphate-buffered saline (PBS) buffer and stored at −80 °C for future use. For protein analyses, the nuclear protein extract was purified using the Nuclei Isolation kit according to the manufacturer’s instructions (Sigma-Aldrich, St. Louis, MO, USA). The nuclear protein extract was used in western blotting.
The expression of AT1 and AT2 receptors was assessed by immunofluorescence in whole cells and isolated nuclei from HMCs by western blotting under the following conditions: I: Control: cells treated with standard medium; II: cells treated with high-glucose medium; III: cells exposed to C-Exos; and IV: cells exposed to HG-Exos.
HMCs were grown on LabTec® coverslips in a standard culture medium and fixed in 3.5% formaldehyde for 15 min at room temperature. The cells were rinsed with PBS and subsequently permeabilized with 0.2% Triton X-100 for 10 min. Whole HMCs cells were incubated overnight with primary antibodies against AT1 (1:100), AT2 (1:100) receptors (Immuny, Brazil). The primary antibody was washed out, and the cells were incubated with secondary antibody (rabbit anti-rabbit diluted 1:50 in PBS) conjugated to tetramethylrhodamine isothiocyanate (TRITC) or fluorescein isothiocyanate (FITC) for 40 minutes at room temperature (in a dark chamber) and then rinsed with PBS. Finally, the cells were incubated with DAPI (4′,6-diamidino-2-phenylindole dihydrochloride, Invitrogen Life Technologies Inc., Gaithersburg, MD, USA) diluted 1:50 in PBS for 15 min to label the nucleus. The reagents were washed out, and the coverslips and slides were mounted with pH 9.0 glycerin/500 mM Na2CO3 and 500 mM NaHCO3 (MERK SA Chemical Industries, Rio de Janeiro, RJ, Brazil). The images were obtained using a confocal microscope (Zeiss LSM 510 META, Carl Zeiss Inc., Jena, Germany) and were digitalized using ZEN software (Zeiss, Germany).
mRNA expression by RT-PCR
The mRNA expression levels of fibronectin, angiotensinogen and β-actin were estimated by quantitative RT-PCR. The total RNA was purified from HMCs by using a commercial phenol and guanidine isothiocyanate-cesium chloride method (TRIzol, Gibco BRL, Rockland, MD, USA) according to the manufacturer’s instructions. A volume of 2 μg of total RNA was treated with DNase (RQ1 RNase-free DNase; Promega, Madison, WI, USA) to avoid genomic DNA contamination. The RNA pellet was resuspended in RNase-free water and reverse transcribed into cDNA by the addition of a mixture containing 0.5 mg/mL oligodeoxythymidylate (oligo-d(T)), 10 mM dithiothreitol (DTT), 0.5 mM deoxynucleoside triphosphates (Amersham Pharmacia Biotech, Uppsala, Sweden) and 200 U reverse transcriptase enzyme (SuperScript RT; Gibco BRL). RT-PCR amplification was performed using the GeneAmp 5700 Sequence Detection System (Applied Biosystems, Foster City, CA, USA), with specific primers for each molecule as follows (forward and reverse, respectively): fibronectin (5′ acccaattccttgctggtatca 3′ and 5′gtatattcggttcccggttcca 3′); angiotensinogen (5′ tcaaaccaggagaggaac 3′ and 5′ agatggcgaacaggaaggg 3′); and β-actin (5′ cctctatgccaacacagtgc 3′ and 5′ acatctgctggaaggtggac 3′). The amplified products were monitored using the SYBR Green I intercalating dye (Molecular Probes, Eugene, OR, USA), which exhibits high fluorescence upon the binding of double-stranded DNA. The fluorescence for each cycle was quantitatively analyzed using the Sequence Detection system (Applied Biosystems). At the end of each PCR run, a melting curve was produced by increasing the temperature from 60 °C to 95 °C at a rate of 2 °C/min, and the fluorescence was measured every 15 s. This technique provided verification of the presence of a single amplification product. The relative gene expression was calculated using the previous PCR conditions under which the amplification curve was logarithmic. The mRNA expression levels were normalized to β-actin, and the results were expressed as arbitrary units, with the control cells as the reference sample.
Cell proliferation using MTT assay
HMCs were plated onto 96-well plates at a density of 103 cells/well. After attachment for 24 hr, the culture medium was replaced according to each group, and the cells were cultured for an additional 24, 48, 72, or 96 hr. The supernatants were discarded, and 200 μL of culture medium containing 0.5% 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was added to each well. After a 4-hr incubation period, the culture medium was carefully removed, and 100 μL of dimethyl sulfoxide (DMSO; Sigma-Aldrich) was added to each well. The cells were placed in an incubator and vortexed at a low speed for 2 min to fully dissolve the formazan crystals. The optical density (OD) of each well was measured at 490 nm using the EON microplate reader (BIOTEK, Winooski, Vermont, USA).
CHO-K1 and CHO-ACE culture
Wild-type Chinese Hamster Ovary cells (CHO-K1) were used as a negative control for AngII synthesis, as these cells do not express any RAS components29, including AT1 and AT2 receptors. CHO-K1 cells were provided by Dr. Guacyara da Motta (Bioquemistry Departament, Federal University of São Paulo, Brazil). This cell line was cultured in Ham’s F-12 nutrient mixture medium (Invitrogen Corporation, Gaithersburg, MD, USA).
CHO-K1 cells were transfected with the angiotensin-converting enzyme (ACE) gene and were kindly provided by Dr. Dulce Casarini (Department of Medicine, Federal University of São Paulo). ACE-transfected CHO-K1 cells (ACE-CHOs) were cultured at 37 °C in culture plates with DMEM, containing 10% FBS, penicillin (50 U/ML) and 2.6 g HEPES. Both cell lines were cultured in plastic plates in a humidified incubator containing 5% CO2 at 37 °C. Culture media were supplemented with 10% (v/v) fetal bovine serum (FBS) and penicillin (50 U/mL).
Statistical analysis
The results are expressed as the means ± standard error of mean (SEM). Statistical significance was determined through one-way analysis of variance (ANOVA), followed by either Newman–Keuls test or Tukey’s test. P-values less than 0.05 were considered statistically significant. Statistical analysis and graph construction were performed using GraphPad Prism software version 5.00 for Windows (GraphPad Software, San Diego, CA, USA).
Supplementary information
Acknowledgements
The authors are grateful to this work was supported by grants from Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível superior (CAPES) and Fundação Oswaldo Ramos and Laboratório Multiusuário 6 – Infar/Unifesp for analyses on Confocal Microscopy. The authors also would like to thank Dr. Dulce Casarini and Dr. Niels Camara for advice and suggestions on this work. This work was supported by grants from Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP). Process Number: 2017/00250-8 and 2015/23345-9.
Author Contributions
Antonio da Silva Novaes, Mirian Aparecida Boim. Formal analysis: Antonio da Silva Novaes, Mirian Aparecida Boim. Funding acquisition: Mirian Aparecida Boim. Investigation: Antonio da Silva Novaes, Fernanda Teixeira Borges. Methodology: Antonio da Silva Novaes, Marcos Vinicios Salles Dias, Fernanda Teixeira Borges, Edgar Maquigussa, Vanessa Varela. Project administration: Antonio da Silva Novaes, Mirian Aparecida Boim. Resources: Antonio da Silva Novaes, Mirian Aparecida Boim. Supervision: Mirian Aparecida Boim. Validation: Mirian Aparecida Boim. Visualization: Antonio da Silva Novaes, Mirian Aparecida Boim. Writing – original draft: Antonio da Silva Novaes, Mirian Aparecida Boim. Writing – review & editing: Antonio da Silva Novaes, Mirian Aparecida Boim.
Competing Interests
The authors declare no competing interests.
Footnotes
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary information accompanies this paper at 10.1038/s41598-019-42746-1.
References
- 1.Bruno S, Porta S, Bussolati B. Extracellular vesicles in renal tissue damage and regeneration. Eur J Pharmacol. 2016;790:83–91. doi: 10.1016/j.ejphar.2016.06.058. [DOI] [PubMed] [Google Scholar]
- 2.Greening DW, Xu R, Ji H, Tauro BJ, Simpson RJ. A protocol for exosome isolation and characterization: evaluation of ultracentrifugation, density-gradient separation, and immunoaffinity capture methods. Methods Mol Biol. 2015;1295:179–209. doi: 10.1007/978-1-4939-2550-6_15. [DOI] [PubMed] [Google Scholar]
- 3.Alenquer M, Amorim MJ. Exosome Biogenesis, Regulation, and Function in Viral Infection. Viruses. 2015;7:5066–5083. doi: 10.3390/v7092862. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Borges FT, et al. TGF-β1-containing exosomes from injured epithelial cells activate fibroblasts to initiate tissue regenerative responses and fibrosis. J Am Soc Nephrol. 2013;24:385–392. doi: 10.1681/ASN.2012101031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Lawson C, Vicencio JM, Yellon DM, Davidson SM. Microvesicles and exosomes: new players in metabolic and cardiovascular disease. J Endocrinol. 2016;228:R57–71. doi: 10.1530/JOE-15-0201. [DOI] [PubMed] [Google Scholar]
- 6.Masyuk AI, Masyuk TV, Larusso NF. Exosomes in the pathogenesis, diagnostics and therapeutics of liver diseases. J Hepatol. 2013;59:621–625. doi: 10.1016/j.jhep.2013.03.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Rice GE, et al. The Effect of Glucose on the Release and Bioactivity of Exosomes From First Trimester Trophoblast Cells. J Clin Endocrinol Metab. 2015;100:E1280–1288. doi: 10.1210/jc.2015-2270. [DOI] [PubMed] [Google Scholar]
- 8.Théry C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. 2006;Chapter 3:Unit 3.22. doi: 10.1002/0471143030.cb0322s30. [DOI] [PubMed] [Google Scholar]
- 9.Kobayashi M, et al. Ovarian cancer cell invasiveness is associated with discordant exosomal sequestration of Let-7 miRNA and miR-200. J Transl Med. 2014;12:4. doi: 10.1186/1479-5876-12-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Lv LH, et al. Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro. J Biol Chem. 2012;287:15874–15885. doi: 10.1074/jbc.M112.340588. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Yu, S., Cao, H., Shen, B. & Feng, J. Tumor-derived exosomes in cancer progression and treatment failure. Oncotarget, 10.18632/oncotarget.6022 (2015). [DOI] [PMC free article] [PubMed]
- 12.Qi Ying, Wang Xiaojing, Rose Kristie L., MacDonald W. Hayes, Zhang Bing, Schey Kevin L., Luther James M. Activation of the Endogenous Renin-Angiotensin-Aldosterone System or Aldosterone Administration Increases Urinary Exosomal Sodium Channel Excretion. Journal of the American Society of Nephrology. 2015;27(2):646–656. doi: 10.1681/ASN.2014111137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteomics. 2010;73:1907–1920. doi: 10.1016/j.jprot.2010.06.006. [DOI] [PubMed] [Google Scholar]
- 14.Vella LJ, et al. Packaging of prions into exosomes is associated with a novel pathway of PrP processing. J Pathol. 2007;211:582–590. doi: 10.1002/path.2145. [DOI] [PubMed] [Google Scholar]
- 15.Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93:137–188. doi: 10.1152/physrev.00045.2011. [DOI] [PubMed] [Google Scholar]
- 16.Dronavalli S, Duka I, Bakris GL. The pathogenesis of diabetic nephropathy. Nat Clin Pract Endocrinol Metab. 2008;4:444–452. doi: 10.1038/ncpendmet0894. [DOI] [PubMed] [Google Scholar]
- 17.Gohda T, Mima A, Moon JY, Kanasaki K. Combat diabetic nephropathy: from pathogenesis to treatment. J Diabetes Res. 2014;2014:207140. doi: 10.1155/2014/207140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Vidotti DB, et al. High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells. Am J Physiol Renal Physiol. 2004;286:F1039–1045. doi: 10.1152/ajprenal.00371.2003. [DOI] [PubMed] [Google Scholar]
- 19.Singh R, Singh AK, Alavi N, Leehey DJ. Mechanism of increased angiotensin II levels in glomerular mesangial cells cultured in high glucose. J Am Soc Nephrol. 2003;14:873–880. doi: 10.1097/01.ASN.0000060804.40201.6E. [DOI] [PubMed] [Google Scholar]
- 20.Alique M, et al. Angiotensin II, via angiotensin receptor type 1/nuclear factor-κB activation, causes a synergistic effect on interleukin-1-β-induced inflammatory responses in cultured mesangial cells. J Renin Angiotensin Aldosterone Syst. 2015;16:23–32. doi: 10.1177/1470320314551564. [DOI] [PubMed] [Google Scholar]
- 21.Okazaki M, et al. The angiotensin II type 1 receptor blocker candesartan suppresses proliferation and fibrosis in gastric cancer. Cancer Lett. 2014;355:46–53. doi: 10.1016/j.canlet.2014.09.019. [DOI] [PubMed] [Google Scholar]
- 22.Singh VP, Le B, Khode R, Baker KM, Kumar R. Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis. Diabetes. 2008;57:3297–3306. doi: 10.2337/db08-0805. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Shihab FS, Bennett WM, Tanner AM, Andoh TF. Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy. Kidney Int. 1997;52:660–673. doi: 10.1038/ki.1997.380. [DOI] [PubMed] [Google Scholar]
- 24.Husain K, Hernandez W, Ansari RA, Ferder L. Inflammation, oxidative stress and renin angiotensin system in atherosclerosis. World J Biol Chem. 2015;6:209–217. doi: 10.4331/wjbc.v6.i3.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Leehey DJ, Singh AK, Alavi N, Singh R. Role of angiotensin II in diabetic nephropathy. Kidney Int Suppl. 2000;77:S93–98. doi: 10.1046/j.1523-1755.2000.07715.x. [DOI] [PubMed] [Google Scholar]
- 26.Gwathmey TM, Alzayadneh EM, Pendergrass KD, Chappell MC. Novel roles of nuclear angiotensin receptors and signaling mechanisms. Am J Physiol Regul Integr Comp Physiol. 2012;302:R518–530. doi: 10.1152/ajpregu.00525.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Yacoub R, Campbell KN. Inhibition of RAS in diabetic nephropathy. Int J Nephrol Renovasc Dis. 2015;8:29–40. doi: 10.2147/IJNRD.S37893. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Wilson BA, Marshall AC, Alzayadneh EM, Chappell MC. The ins and outs of angiotensin processing within the kidney. Am J Physiol Regul Integr Comp Physiol. 2014;307:R487–489. doi: 10.1152/ajpregu.00177.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Barauna VG, Campos LC, Miyakawa AA, Krieger JE. ACE as a mechanosensor to shear stress influences the control of its own regulation via phosphorylation of cytoplasmic Ser(1270) PLoS One. 2011;6:e22803. doi: 10.1371/journal.pone.0022803. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Ignjacev-Lazich I, et al. Angiotensin-converting enzyme regulates bradykinin receptor gene expression. Am J Physiol Heart Circ Physiol. 2005;289:H1814–1820. doi: 10.1152/ajpheart.00581.2005. [DOI] [PubMed] [Google Scholar]
- 31.Ramchandran R, Sen GC, Misono K, Sen I. Regulated cleavage-secretion of the membrane-bound angiotensin-converting enzyme. J Biol Chem. 1994;269:2125–2130. [PubMed] [Google Scholar]
- 32.Zeringer E, Barta T, Li M, Vlassov AV. Strategies for isolation of exosomes. Cold Spring Harb Protoc. 2015;2015:319–323. doi: 10.1101/pdb.top074476. [DOI] [PubMed] [Google Scholar]
- 33.Momen-Heravi F, Bala S, Kodys K, Szabo G. Exosomes derived from alcohol-treated hepatocytes horizontally transfer liver specific miRNA-122 and sensitize monocytes to LPS. Sci Rep. 2015;5:9991. doi: 10.1038/srep09991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Clayton A, Turkes A, Navabi H, Mason MD, Tabi Z. Induction of heat shock proteins in B-cell exosomes. J Cell Sci. 2005;118:3631–3638. doi: 10.1242/jcs.02494. [DOI] [PubMed] [Google Scholar]
- 35.Hedlund M, Nagaeva O, Kargl D, Baranov V, Mincheva-Nilsson L. Thermal- and oxidative stress causes enhanced release of NKG2D ligand-bearing immunosuppressive exosomes in leukemia/lymphoma T and B cells. PLoS One. 2011;6:e16899. doi: 10.1371/journal.pone.0016899. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Borges FT, Reis LA, Schor N. Extracellular vesicles: structure, function, and potential clinical uses in renal diseases. Braz J Med Biol Res. 2013;46:824–830. doi: 10.1590/1414-431X20132964. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Parolini I, et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem. 2009;284:34211–34222. doi: 10.1074/jbc.M109.041152. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Burns KD. Angiotensin II and its receptors in the diabetic kidney. Am J Kidney Dis. 2000;36:449–467. doi: 10.1053/ajkd.2000.16192. [DOI] [PubMed] [Google Scholar]
- 39.Abe H. Pathogenesis and diagnosis of diabetic nephropathy. Nihon Rinsho. 2012;70 Suppl 5:402–406. [PubMed] [Google Scholar]
- 40.Cristovam PC, et al. ACE-dependent and chymase-dependent angiotensin II generation in normal and glucose-stimulated human mesangial cells. Exp Biol Med (Maywood) 2008;233:1035–1043. doi: 10.3181/0708-RM-229. [DOI] [PubMed] [Google Scholar]
- 41.Wang J, et al. Effects of Free Anthraquinones Extract from the Rhubarb on Cell Proliferation and Accumulation of Extracellular Matrix in High Glucose Cultured-Mesangial Cells. Korean J Physiol Pharmacol. 2015;19:485–489. doi: 10.4196/kjpp.2015.19.6.485. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Liu Y, et al. Role of caveolae in high glucose and TGF-β1 induced fibronectin production in rat mesangial cells. Int J Clin Exp Pathol. 2014;7:8381–8390. [PMC free article] [PubMed] [Google Scholar]
- 43.Gu J, Ye S, Wang S, Sun W, Hu Y. Metformin inhibits nuclear factor-κB activation and inflammatory cytokines expression induced by high glucose via adenosine monophosphate-activated protein kinase activation in rat glomerular mesangial cells in vitro. Chin Med J (Engl) 2014;127:1755–1760. [PubMed] [Google Scholar]
- 44.Roy S, Bae E, Amin S, Kim D. Extracellular matrix, gap junctions, and retinal vascular homeostasis in diabetic retinopathy. Exp Eye Res. 2015;133:58–68. doi: 10.1016/j.exer.2014.08.011. [DOI] [PubMed] [Google Scholar]
- 45.Zhang GY, et al. Sitagliptin ameliorates high glucose-induced cell proliferation and expression of the extracellular matrix in glomerular mesangial cells. Exp Ther Med. 2017;14:3862–3867. doi: 10.3892/etm.2017.5002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Lu Y, Tang L, Li Y, He Q. High glucose-induced fibronectin upregulation in cultured mesangial cells involves caveolin-1-dependent RhoA-GTP activation via Src kinase. Mol Med Rep. 2016;14:963–968. doi: 10.3892/mmr.2016.5312. [DOI] [PubMed] [Google Scholar]
- 47.da Silva Novaes A, Ribeiro RS, Pereira LG, Borges FT, Boim MA. Intracrine action of angiotensin II in mesangial cells: subcellular distribution of angiotensin II receptor subtypes AT. Mol Cell Biochem. 2018;448:265–274. doi: 10.1007/s11010-018-3331-y. [DOI] [PubMed] [Google Scholar]
- 48.Re R. Intracellular renin-angiotensin system: the tip of the intracrine physiology iceberg. Am J Physiol Heart Circ Physiol. 2007;293:H905–906. doi: 10.1152/ajpheart.00552.2007. [DOI] [PubMed] [Google Scholar]
- 49.Re RN. The cellular biology of angiotensin: paracrine, autocrine and intracrine actions in cardiovascular tissues. J Mol Cell Cardiol. 1989;21(Suppl 5):63–69. doi: 10.1016/0022-2828(89)90772-4. [DOI] [PubMed] [Google Scholar]
- 50.Re RN, Cook JL. Senescence, apoptosis, and stem cell biology: the rationale for an expanded view of intracrine action. Am J Physiol Heart Circ Physiol. 2009;297:H893–901. doi: 10.1152/ajpheart.00414.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Banas B, et al. Chemokine and chemokine receptor expression in a novel human mesangial cell line. J Am Soc Nephrol. 1999;10:2314–2322. doi: 10.1681/ASN.V10112314. [DOI] [PubMed] [Google Scholar]
- 52.Pereira LG, et al. Pro)renin receptor: another member of the system controlled by angiotensin II? J Renin Angiotensin Aldosterone Syst. 2012;13:1–10. doi: 10.1177/1470320311423280. [DOI] [PubMed] [Google Scholar]
- 53.Ho YF, Guenthner TM. Isolation of liver nuclei that retain functional trans-membrane transport. J Pharmacol Toxicol Methods. 1997;38:163–168. doi: 10.1016/S1056-8719(97)00082-8. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.